Videos

Guillermo Garcia-Manero, MD, from MD Anderson Cancer Center, characterizes the clinical outcome improvements observed with luspatercept for lower-risk myelodysplastic syndromes in clinical practice. View Video ›

Guillermo Garcia-Manero, MD, from MD Anderson Cancer Center, explores imetelstat trial results of patients with transfusion-dependent lower-risk myelodysplastic syndromes who experience failure to or are ineligible for treatment with erythropoiesis-stimulating agents. View Video ›

Guillermo Garcia-Manero, MD, from MD Anderson Cancer Center, explores imetelstat trial results of patients with transfusion-dependent lower-risk myelodysplastic syndromes who experience failure to or are ineligible for treatment with erythropoiesis-stimulating agents. View Video ›

Please join Guillermo Garcia-Manero, MD, from MD Anderson Cancer Center, as he discusses how the clinical benefits of luspatercept could lead to a new standard of care for patients with transfusion-dependent lower-risk myelodysplastic syndromes. View Video ›

Helping Patients with Multiple Myeloma Comply with Their Therapy Requires a Team Approach
Successfully getting patients with multiple myeloma to follow their therapy regimen often requires a team approach. Please join Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, as they outline which team members they utilize and how they use this technique at their institutions. View Video ›

Accumulating Adverse Events May Cause Patients with Multiple Myeloma to Be Reluctant to Adhere to Their Treatment Plan
Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, discuss how they use shared decision-making with patients to help them remain adherent to their treatment plan. View Video ›

Who Are the Patients with Multiple Myeloma Who May Not Adhere to Their Treatment Regimen?
Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, talk about the clues and the patient characteristics that they use to determine which of their patients with multiple myeloma may be at risk for not adhering to their anticancer therapy. View Video ›

Best Practices for Keeping Patients with Multiple Myeloma Adherent to Therapy
Patients with multiple myeloma often face a difficult road in their cancer journey because of their treatment regimen. Please join Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, as they share some of their best practices for keeping patients on therapy. View Video ›

Patients with Multiple Myeloma Harbor Misconceptions About Treatment Adherence
Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, break down the misconceptions that patients with multiple myeloma may have about the different treatment regimens and how those misconceptions can affect their views on treatment adherence. View Video ›

Breaking Down Barriers to Treatment Adherence for Patients with Multiple Myeloma
Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, discuss the multiple potential barriers to treatment adherence that some patients with multiple myeloma may face in their cancer journey and how they utilize some of their best practices to keep patients on therapy. View Video ›

Page 1 of 12


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: